Registered record
Number: 04658880
Type: ltd
Registered office: Creo House Unit 2, Beaufort Park, Beaufort Park Way, Chepstow, NP16 5UH, United Kingdom
SIC: 72190
Current statusactive
Incorporated6 February 2003
Accounts due30 September 2027
Confirmation due6 November 2026
Status checked via live Companies House proxy at 16 August 2026. This is a public-record research page, not a credit score, investment conclusion or tax determination.
Identity and review status
1 mapped fund association
Association means the company appeared in the dated portfolio research corpus. It does not prove a fund's current holding or SEIS/EIS eligibility.
Companies House
Open complete official history →Filing timeline
Recent events are shown newest first. Filing codes and dates come directly from Companies House; descriptions are concise labels, not legal interpretations.
- Accounts made up to 31 December 2025
AA· Accounts - Mortgage
MR01· Mortgage - Mortgage
MR01· Mortgage - Confirmation Statement made up to 23 October 2025
CS01· Confirmation Statement - Accounts made up to 31 December 2024
AA· Accounts - Confirmation Statement made up to 24 November 2024
CS01· Confirmation Statement - Officers — Richard Rees
TM02· Officers - Officers — Mr Richard Gary Craven
AP03· Officers - Accounts made up to 31 December 2023
AA· Accounts - Confirmation Statement made up to 24 November 2023
CS01· Confirmation Statement - Accounts made up to 31 December 2022
AA· Accounts - Address
AD02· Address - Confirmation Statement made up to 24 November 2022
CS01· Confirmation Statement - Accounts made up to 31 December 2021
AA· Accounts - Confirmation Statement made up to 24 November 2021
CS01· Confirmation Statement - Address
AD03· Address
Ownership and control timeline
People with significant control (PSC) records describe published legal control, not a complete economic ownership graph. CompanyBeacon does not infer control from names.
1 active control record
- Creo Medical Group PlcNotified 9 December 2016 · current in returned recordOwnership Of Shares 75 To 100 Percent; Voting Rights 75 To 100 Percent; Right To Appoint And Remove Directors
- Mr Richard John ReesNotified 1 July 2016 · ceased 9 November 2016Significant Influence Or Control; Significant Influence Or Control As Firm
- Mr Craig Jonathan GullifordNotified 6 April 2016 · ceased 9 November 2016Significant Influence Or Control; Significant Influence Or Control As Firm
- Dr Christopher Paul HancockNotified 6 April 2016 · ceased 9 November 2016Significant Influence Or Control; Significant Influence Or Control As Firm
- Mr Steven MorrisNotified 6 April 2016 · ceased 9 November 2016Significant Influence Or Control; Significant Influence Or Control As Firm
4 active officers
- Richard Gary CRAVENSecretary · appointed 1 July 2024
- Craig Jonathan GULLIFORDDirector · appointed 30 March 2012
- Christopher Paul, Prof HANCOCKDirector · appointed 20 February 2003
- Richard John REESDirector · appointed 1 July 2016
Exact GB-COH join
Open full supplier profile →Supplier and public-money context
Published notices1
Distinct buyers1
Disclosed value£426,000,000
Latest notice31 July 2025
The Contracts Finder supplier identifier resolves exactly to Companies House number 04658880. Values are notice fields, not verified revenue; frameworks and multi-supplier awards can overstate totals.
| Published | Buyer and notice | Award value |
|---|---|---|
| 31 July 2025 | Endoscopy, Endourology & Oncology Ablation Consumables & Associated Products Supply Chain Coordination Limited Catheters | £426,000,000 |
Source dates and limitations
- charity-commission-register: extract Not available, imported 25 July 2026.
- companies-house-relevant-subset: extract Not available, imported 25 July 2026.
- contracts-finder-daily-csv: extract 24 July 2026, imported 25 July 2026.
- Live status, filings, officers and PSC records can change after this page is cached. Companies House remains authoritative.
- SEIS/EIS qualification, investment performance, creditworthiness and beneficial ownership are not inferred.